<DOC>
	<DOC>NCT02418390</DOC>
	<brief_summary>The aim of this study is to investigate the efficacy and safety of prophylactic central lymph node dissection in papillary thyroid carcinoma.</brief_summary>
	<brief_title>The Efficacy and Safety of Prophylactic Central Lymph Node Dissection in Papillary Thyroid Carcinoma</brief_title>
	<detailed_description>The aim of this study is to investigate the efficacy and safety of prophylactic central lymph node dissection in papillary thyroid carcinoma. Primary outcome is the structural recurrence rate. Secondary outcomes are operative time, postoperative complications, and quality of life. The enrolled patients were randomly assigned to control group and intervention group (1:1 allocation).</detailed_description>
	<mesh_term>Thyroid Diseases</mesh_term>
	<mesh_term>Thyroid Neoplasms</mesh_term>
	<mesh_term>Carcinoma</mesh_term>
	<criteria>no clinical and radiological evidence of lymph node metastasis no evidence of hyperparathyroidism pregnant women uncontrolled diabetes, hypertension, or chronic renal failure aspirin or anticoagulant medication within 7 days other clinical trial participation within 30 days radiation exposure to the head and neck previous operation to the neck advanced thyroid cancer including adjacent organ invasion</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>